Document Detail


Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
MedLine Citation:
PMID:  19332471     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: A fetus exposed to maternal anti-SSA/Ro or anti-SSB/La antibodies (or both) may develop complete atrioventricular block (AVB), which results in high prenatal and postnatal morbidity and mortality. Until recently, only high-grade AVB could be diagnosed in utero. The tissue velocity-based fetal kinetocardiogram (FKCG) enables accurate measurement of AV conduction time and diagnosis of low-grade AVB. In the present multicenter observational study, we used FKCG to detect first-degree AVB in fetuses at risk. METHODS AND RESULTS: FKCG was performed in 70 fetuses of 56 mothers who were positive for anti-SSA/Ro and/or anti-SSB/La. Fetuses were monitored with weekly FKCG from 13 to 24 weeks' gestation, followed by monthly assessments until delivery in unaffected fetuses and weekly assessments in affected fetuses. AV conduction in 70 at-risk and 109 normal fetuses was compared. FKCG was obtained readily in all fetuses; 6 showed first-degree AVB (AV conduction time >2 z scores above normal mean) at 21 to 34 gestational weeks. Immediate maternal treatment with dexamethasone resulted in normalization of AV conduction in all affected fetuses within 3 to 14 days. AV conduction time in the remaining 64 untreated fetuses remained normal throughout gestation. The ECG PR interval immediately after birth was normal in all affected newborns. No child developed AVB or cardiomyopathy in the subsequent 1- to 6-year (median 4-year) follow-up. CONCLUSIONS: The present findings suggest that an FKCG can detect first-degree AVB in the fetus exposed to maternal anti-SSA/Ro or anti-SSB/La antibodies (or both). Dexamethasone given on detection was associated with normalized AV conduction in fetuses with first-degree AVB. No fetus in the present study developed complete prenatal or postnatal AVB.
Authors:
A J J T Rein; D Mevorach; Z Perles; S Gavri; M Nadjari; A Nir; U Elchalal
Publication Detail:
Type:  Journal Article     Date:  2009-03-30
Journal Detail:
Title:  Circulation     Volume:  119     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-14     Completed Date:  2009-05-14     Revised Date:  2009-11-25    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1867-72     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatric Cardiology, Hadassah-Hebrew University Medical Center, Kiryat Hadassah, Jerusalem, Israel. rein@huji.ac.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Antinuclear / blood*
Atrioventricular Block / drug therapy,  embryology*,  ultrasonography*
Autoantibodies / blood*
Dexamethasone / therapeutic use
Female
Fetal Diseases / diagnosis*,  immunology
Humans
Infant, Newborn
Kinetocardiography
Lupus Erythematosus, Systemic / immunology,  physiopathology
Pregnancy
Pregnancy Trimester, Second
Prenatal Diagnosis
Ultrasonography, Prenatal
Chemical
Reg. No./Substance:
0/Antibodies, Antinuclear; 0/Autoantibodies; 0/SS-A antibodies; 0/SS-B antibodies; 50-02-2/Dexamethasone
Comments/Corrections
Comment In:
Circulation. 2009 Nov 24;120(21):e167; author reply e168   [PMID:  19933947 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular imaging of innate immune cell function in transplant rejection.
Next Document:  Expression profiling of microRNAs by deep sequencing.